Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | VDR | P11473 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | F2 | P00734 | 2/20 | 0.40 |
| ▸ | XBP1 | P17861 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL262472 | 0.75 | GAA (0.56) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL20768726 | 0.75 | GAA (0.56) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL3359433 | 0.73 | GAA (0.54) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL3863655 | 0.71 | GAA (0.52) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL798345 | 0.71 | GAA (0.52) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL19341881 | 0.71 | GAA (0.52) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL12963641 | 0.71 | GAA (0.52) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL14159314 | 0.71 | GAA (0.52) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL13286163 | 0.71 | GAA (0.52) | GAAALDH1A1KMT2AMAPTKDM4E | |
| SCHEMBL17516239 | 0.71 | GAA (0.52) | GAAALDH1A1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1700922-B1 | 3-Substituted 5-Nitroindole derivatives and labeled oligonucleotide probes containing them | ROCHE DIAGNOSTICS GMBH (DE) | 2016-08-24 | — | — | EP | claimed |
| EP-1594855-B1 | SIGNALLING COMPOUNDS FOR USE IN METHODS OF DETECTING HYDROGEN PEROXIDE | LUMIGEN INC (US) | 2014-01-22 | — | — | EP | claimed |
| EP-2305690-B1 | Signalling compounds for use in methods of detecting hydrogen peroxide | LUMIGEN INC (US) | 2012-08-29 | — | — | EP | claimed |
| EP-2305690-A1 | Signalling compounds for use in methods of detecting hydrogen peroxide | LUMIGEN, INC. (US) | 2011-04-06 | — | — | EP | claimed |
| US-7695980-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2010-04-13 | — | — | US | claimed |
| US-7691367-B2 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-04-06 | — | — | US | claimed |
| EP-1646609-B1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2009-10-14 | — | — | EP | claimed |
| US-7563902-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2009-07-21 | — | — | US | claimed |
| US-7547765-B2 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2009-06-16 | — | — | US | claimed |
| US-20080125350-A1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-05-29 | — | — | US | claimed |
| US-20040166539-A1 | Signalling compounds and methods for detecting hydrogen peroxide | LUMIGEN, INC. | 2004-08-26 | — | — | US | claimed |
| EP-1400550-A1 | BRANCHED POLYALKYLENE GLYCOLS | Kyowa Hakko Kogyo Co., Ltd (JP) | 2004-03-24 | — | — | EP | claimed |
| US-20030219404-A1 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2003-11-27 | — | — | US | claimed |
| EP-0609885-B1 | Acridinium compounds and conjugates thereof | MOCHIDA PHARM CO LTD (JP) | 2003-04-16 | — | — | EP | claimed |
| EP-1270642-A1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-01-02 | — | — | EP | claimed |
| US-6087502-A | COMPOUNDS FOR MARKING ANTIGENS OR ANTIBODIES RECEPTOR BINDING ASSAY | MOCHIDA PHARMACEUTICALS CO., LTD. (JP) | 2000-07-11 | — | — | US | claimed |
| EP-0761652-A1 | Acridinium compound having a plurality of luminescent groups and binding groups, and conjugate thereof | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1997-03-12 | — | — | EP | claimed |
| US-5594112-A | CHEMILUMINESCENCE LABEL | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1997-01-14 | — | — | US | claimed |
| US-5438139-A | Chemiluminescent; useful as immunolochemical, DNA probe and receptor bininding assays | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1995-08-01 | — | — | US | claimed |
| EP-0609885-A1 | Acridinium compounds and conjugates thereof | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1994-08-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125350-A1 | BRANCHED POLYALKYLENE GLYCOLS | LNPEP, ANPEP, ENPEP | GAA 628/4885ALDH1A1 2967/4885KMT2A 4612/4885 |
| US-20030219404-A1 | Branched polyalkylene glycols | LNPEP, ANPEP, BCAT1 | GAA 561/4885ALDH1A1 2572/4885KMT2A 4365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.